Clipping cancer with CRISPR: The precise gene-editing tool is showing promise in early cancer studies, although obstacles remain.
Cancer cytopathology, 126(1): 7-8 PMID 29328557 DOI 10.1002/cncy.21964
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.